Neriagenin

Details

Top
Internal ID 9396fc24-4076-4781-865a-be2da127a77c
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene lactones
IUPAC Name 3-[(1R,2R,3S)-2-[2-[(1R,4aR,6S,8aS)-6-[(2R,4R,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-8a-methyl-2-oxo-1,3,4,4a,5,6,7,8-octahydronaphthalen-1-yl]ethyl]-3-hydroxy-2-methylcyclopentyl]-2H-furan-5-one
SMILES (Canonical) CC1C(C(CC(O1)OC2CCC3(C(C2)CCC(=O)C3CCC4(C(CCC4O)C5=CC(=O)OC5)C)C)OC)OC6C(C(C(C(O6)CO)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CCC(=O)[C@@H]3CC[C@@]4([C@H](CC[C@@H]4O)C5=CC(=O)OC5)C)C)OC)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O
InChI InChI=1S/C36H56O13/c1-18-33(49-34-32(43)31(42)30(41)26(16-37)48-34)25(44-4)15-29(46-18)47-21-9-11-35(2)20(14-21)5-7-24(38)23(35)10-12-36(3)22(6-8-27(36)39)19-13-28(40)45-17-19/h13,18,20-23,25-27,29-34,37,39,41-43H,5-12,14-17H2,1-4H3/t18-,20-,21+,22-,23+,25-,26-,27+,29+,30-,31+,32-,33+,34+,35+,36-/m1/s1
InChI Key HWLQHFSNEUZBOA-IJOJEBQMSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C36H56O13
Molecular Weight 696.80 g/mol
Exact Mass 696.37209184 g/mol
Topological Polar Surface Area (TPSA) 191.00 Ų
XlogP 0.90
Atomic LogP (AlogP) 1.53
H-Bond Acceptor 13
H-Bond Donor 5
Rotatable Bonds 10

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Neriagenin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7964 79.64%
Caco-2 - 0.8728 87.28%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.8047 80.47%
OATP2B1 inhibitior - 0.8679 86.79%
OATP1B1 inhibitior + 0.8793 87.93%
OATP1B3 inhibitior + 0.9615 96.15%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.8363 83.63%
P-glycoprotein inhibitior + 0.7155 71.55%
P-glycoprotein substrate + 0.7262 72.62%
CYP3A4 substrate + 0.7304 73.04%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9003 90.03%
CYP3A4 inhibition - 0.8841 88.41%
CYP2C9 inhibition - 0.9054 90.54%
CYP2C19 inhibition - 0.9238 92.38%
CYP2D6 inhibition - 0.9467 94.67%
CYP1A2 inhibition - 0.9221 92.21%
CYP2C8 inhibition + 0.4687 46.87%
CYP inhibitory promiscuity - 0.9513 95.13%
UGT catelyzed - 0.7000 70.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5527 55.27%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.9235 92.35%
Skin irritation - 0.5611 56.11%
Skin corrosion - 0.9387 93.87%
Ames mutagenesis - 0.6354 63.54%
Human Ether-a-go-go-Related Gene inhibition + 0.7221 72.21%
Micronuclear - 0.7700 77.00%
Hepatotoxicity - 0.7500 75.00%
skin sensitisation - 0.9209 92.09%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity - 0.7214 72.14%
Acute Oral Toxicity (c) I 0.8305 83.05%
Estrogen receptor binding + 0.7838 78.38%
Androgen receptor binding + 0.7296 72.96%
Thyroid receptor binding - 0.6679 66.79%
Glucocorticoid receptor binding + 0.6594 65.94%
Aromatase binding + 0.6608 66.08%
PPAR gamma + 0.6612 66.12%
Honey bee toxicity - 0.6160 61.60%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9314 93.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.43% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 96.32% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.71% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.54% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 94.78% 100.00%
CHEMBL2581 P07339 Cathepsin D 93.02% 98.95%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 90.71% 96.77%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.27% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.06% 95.56%
CHEMBL253 P34972 Cannabinoid CB2 receptor 88.45% 97.25%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.81% 85.14%
CHEMBL1871 P10275 Androgen Receptor 85.37% 96.43%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.36% 95.89%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 85.29% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 83.60% 94.00%
CHEMBL5255 O00206 Toll-like receptor 4 83.51% 92.50%
CHEMBL226 P30542 Adenosine A1 receptor 82.72% 95.93%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 81.75% 97.33%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 81.29% 92.86%
CHEMBL5028 O14672 ADAM10 81.18% 97.50%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.59% 94.33%

Cross-Links

Top
PubChem 51040390
NPASS NPC3946